Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 27 peer-reviewed journal articles Updated
Neurology

Treating Orthostatic Hypotension in PAF

At a Glance

Treatment for orthostatic hypotension in pure autonomic failure is individualized: start with an abdominal binder, carefully supervised salt and fluid planning, and smaller meals, then consider midodrine or droxidopa under clinician supervision, with regular lying and standing blood-pressure checks.

Managing the blood pressure drops in Pure Autonomic Failure (PAF) is not about reaching “normal” numbers (like 120/80). Instead, the goal of treatment is to improve your quality of life, reduce your symptoms, and prevent falls so you can stay active [1][2]. Doctors use a “stepwise” approach, starting with lifestyle changes before moving to medications [3][4].

Step 1: Non-Drug Strategies

Before adding medications, several simple physical and dietary changes can help stabilize your blood pressure [4]. These must be individualized and clinician-supervised.

  • Abdominal Binders: Systematic reviews strongly recommend using an abdominal binder—a wide, elastic wrap around your belly [4]. By compressing the large veins in your abdomen, it prevents blood from pooling there when you stand, pushing more blood back toward your heart and brain [4][5].
  • The Water “Bolus”: Drinking 16 ounces (480 mL) of water quickly can trigger a natural reflex that raises blood pressure for about an hour [6][7]. Caution: The magnitude varies, and this may worsen supine hypertension or be unsuitable if you have heart failure, kidney disease, or are on fluid restriction.
  • Physical Counter-Maneuvers: Learning to cross your legs, tense your leg and buttock muscles, or squat when you feel lightheaded can provide a quick, temporary boost in blood pressure [8][9].
  • Salt and Fluid: Clinical guidelines often mention increasing dietary salt (not just sodium) to 6–10 grams per day to help expand your blood volume [10]. Caution: This is not appropriate for everyone and must be supervised, as it can aggravate supine hypertension and leg swelling [10][11].
  • Meal Adjustments: Large, carbohydrate-rich meals pull blood toward your digestive system, worsening your symptoms. Eating smaller, more frequent meals can help [12][13].

Step 2: First-Line Medications

If lifestyle changes aren’t enough, doctors typically turn to medications specifically suited for peripheral nerve damage [14][2]. Both require careful prescriber supervision and should never be adjusted on your own.

  • Midodrine: Works by tightening your blood vessels [15]. It has a strong track record for raising standing blood pressure, but the last dose must be taken several hours before bed to avoid severe nighttime high blood pressure [16]. It can also cause urinary retention, scalp tingling, and itching.
  • Droxidopa: An oral medication enzymatically converted into norepinephrine [17][2]. While some patients respond well, it does not simply replace a universally “missing” messenger, and a lower risk of supine hypertension than midodrine is not guaranteed for every patient [15][18]. Side effects can include headache, nausea, fatigue, and hypertension.

Step 3: Second-Line Options and Cautions

Fludrocortisone is an older medication sometimes used to help the body retain salt and water [10]. However, it is often avoided or used only with specialist oversight in PAF due to significant risks [4][19]:

  • Weak Evidence: Recent reviews suggest the evidence that it actually improves symptoms is very uncertain [20].
  • Supine Hypertension: It can significantly worsen high blood pressure when you are lying down [21][22].
  • Fluid Overload: It can cause leg swelling (edema) and poses a major risk if you have heart or kidney failure [10][23].
  • Low Potassium: It can cause your potassium levels to drop dangerously low, which requires regular blood test monitoring [24][25].

Creating a Safe Measurement Routine

Because your blood pressure will fluctuate, home monitoring is vital. Use a validated upper-arm cuff. Rest quietly before readings, stand with support, and keep a log of your symptoms, blood pressure (lying and standing), and medication timing to review with your doctor [26][27].

Common questions in this guide

What is the goal of treatment for orthostatic hypotension in PAF?
The goal is to improve daily function and quality of life, reduce lightheadedness and other symptoms, and lower the risk of falls. Treatment is not necessarily meant to make every blood-pressure reading reach 120/80; your clinician will set individualized goals.
Can an abdominal binder or drinking water improve low blood pressure when I stand?
An abdominal binder can reduce blood pooling in the abdomen, and quickly drinking about 16 ounces of water may raise blood pressure for a limited time. These measures are not appropriate for everyone, especially people with fluid restrictions, heart failure, kidney disease, or high blood pressure when lying down, so ask your clinician before using them.
Which medicines are usually considered first for PAF-related orthostatic hypotension?
Midodrine and droxidopa are commonly considered first-line medicines when lifestyle measures are not enough. Midodrine tightens blood vessels and should not be taken close to bedtime, while droxidopa is converted to norepinephrine; both require prescriber supervision and can raise blood pressure when you are lying down.
Why do I need to check my blood pressure lying down and standing up?
PAF-related blood pressure can change with position, and medicines or salt and fluid changes can cause high blood pressure when you are lying down. Use a validated upper-arm cuff, rest before readings, stand with support, and record your symptoms, readings, and medication timing for review with your clinician.
What are the risks of using fludrocortisone for PAF?
Fludrocortisone may help the body retain salt and water, but evidence that it improves symptoms is uncertain. It can worsen high blood pressure when lying down, cause leg swelling or dangerously low potassium, and pose particular risks with heart or kidney failure, so regular blood tests and specialist oversight may be needed.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Pure autonomic failure.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my PAF diagnosis, do you recommend midodrine or droxidopa as my first-line medication, and what are the pros and cons of each for me?
  2. 2.What is my target blood pressure when standing, and what should we consider a 'too high' reading when I am lying down?
  3. 3.How often should we monitor my potassium levels and kidney function if we decide to use fludrocortisone?
  4. 4.Are there any medications I am currently taking—including over-the-counter supplements—that might be making my orthostatic hypotension worse?
  5. 5.If my symptoms don't improve with the current plan, what is the next step in our treatment ladder?

References

References (27)
  1. 1

    Management of Orthostatic Hypotension.

    Palma JA, Kaufmann H

    Continuum (Minneapolis, Minn.) 2020; (26(1)):154-177 doi:10.1212/CON.0000000000000816.

    PMID: 31996627
  2. 2

    Neurogenic Orthostatic Hypotension. Lessons From Synucleinopathies.

    Idiaquez JF, Idiaquez J, Casar JC, Biaggioni I

    American journal of hypertension 2021; (34(2)):125-133 doi:10.1093/ajh/hpaa131.

    PMID: 33705537
  3. 3

    Orthostatic Hypotension: JACC State-of-the-Art Review.

    Freeman R, Abuzinadah AR, Gibbons C, et al.

    Journal of the American College of Cardiology 2018; (72(11)):1294-1309 doi:10.1016/j.jacc.2018.05.079.

    PMID: 30190008
  4. 4

    Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms.

    Eschlböck S, Wenning G, Fanciulli A

    Journal of neural transmission (Vienna, Austria : 1996) 2017; (124(12)):1567-1605 doi:10.1007/s00702-017-1791-y.

    PMID: 29058089
  5. 5

    Managed care approach to the treatment of neurogenic orthostatic hypotension.

    Isaacson SH

    The American journal of managed care 2015; (21(13 Suppl)):s258-68.

    PMID: 26790110
  6. 6

    The Pharmacology of Autonomic Failure: From Hypotension to Hypertension.

    Biaggioni I

    Pharmacological reviews 2017; (69(1)):53-62 doi:10.1124/pr.115.012161.

    PMID: 28011746
  7. 7

    Neurogenic orthostatic hypotension: roles of norepinephrine deficiency in its causes, its treatment, and future research directions.

    Loavenbruck A, Sandroni P

    Current medical research and opinion 2015; (31(11)):2095-104 doi:10.1185/03007995.2015.1087988.

    PMID: 26373628
  8. 8

    Non-Pharmacological Treatment of Autonomic Dysfunction in Parkinson's Disease and Other Synucleinopathies.

    Palma JA, Thijs RD

    Journal of Parkinson's disease 2024; (14(s1)):S81-S92 doi:10.3233/JPD-230173.

    PMID: 37694308
  9. 9

    Strategies for Non-Pharmacological Management of Orthostatic Hypotension in Older People: Bridging Pathophysiology and Practice.

    Owen CM, Frith J

    British journal of hospital medicine (London, England : 2005) 2025; (86(12)):1-17 doi:10.12968/hmed.2024.0956.

    PMID: 41443211
  10. 10

    Blood pressure regulation in autonomic failure by dietary sodium, blood volume and posture.

    Biaggioni I

    Autonomic neuroscience : basic & clinical 2021; (236()):102891 doi:10.1016/j.autneu.2021.102891.

    PMID: 34634681
  11. 11

    Oral and intravenous hydration in the treatment of orthostatic hypotension and postural tachycardia syndrome.

    Snapper H, Cheshire WP

    Autonomic neuroscience : basic & clinical 2022; (238()):102951 doi:10.1016/j.autneu.2022.102951.

    PMID: 35123367
  12. 12

    Atomoxetine for Orthostatic Hypotension in an Elderly Patient Over 10 Weeks: A Case Report.

    Hale GM, Brenner M

    Pharmacotherapy 2015; (35(9)):e141-8 doi:10.1002/phar.1635.

    PMID: 26406777
  13. 13

    Dysautonomia: A Forgotten Condition - Part 1.

    Rocha EA, Mehta N, Távora-Mehta MZP, et al.

    Arquivos brasileiros de cardiologia 2021; (116(4)):814-835 doi:10.36660/abc.20200420.

    PMID: 33886735
  14. 14

    Pharmacologic treatment of orthostatic hypotension.

    Park JW, Okamoto LE, Shibao CA, Biaggioni I

    Autonomic neuroscience : basic & clinical 2020; (229()):102721 doi:10.1016/j.autneu.2020.102721.

    PMID: 32979782
  15. 15

    Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials.

    Chen JJ, Han Y, Tang J, et al.

    The Annals of pharmacotherapy 2018; (52(12)):1182-1194 doi:10.1177/1060028018786954.

    PMID: 29972032
  16. 16

    Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment.

    Hauser RA, Favit A, Hewitt LA, et al.

    Neurology and therapy 2022; (11(1)):459-469 doi:10.1007/s40120-021-00317-5.

    PMID: 35107750
  17. 17

    Supine plasma NE predicts the pressor response to droxidopa in neurogenic orthostatic hypotension.

    Palma JA, Norcliffe-Kaufmann L, Martinez J, Kaufmann H

    Neurology 2018; (91(16)):e1539-e1544 doi:10.1212/WNL.0000000000006369.

    PMID: 30232253
  18. 18

    Long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension.

    Isaacson S, Vernino S, Ziemann A, et al.

    Journal of the American Society of Hypertension : JASH 2016; (10(10)):755-762 doi:10.1016/j.jash.2016.07.010.

    PMID: 27614923
  19. 19

    Management of Orthostatic Hypotension: A Review.

    Moloney D, Youssef A, Okamoto LE

    JAMA internal medicine 2026; doi:10.1001/jamainternmed.2026.0284.

    PMID: 41941194
  20. 20

    Fludrocortisone for orthostatic hypotension.

    Veazie S, Peterson K, Ansari Y, et al.

    The Cochrane database of systematic reviews 2021; (5()):CD012868 doi:10.1002/14651858.CD012868.pub2.

    PMID: 34000076
  21. 21

    Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial.

    Schreglmann SR, Büchele F, Sommerauer M, et al.

    European journal of neurology 2017; (24(4)):545-551 doi:10.1111/ene.13260.

    PMID: 28224720
  22. 22

    Supine hypertension: A state of the art.

    Mantovani G, Marozzi I, Rafanelli M, et al.

    Autonomic neuroscience : basic & clinical 2022; (241()):102988 doi:10.1016/j.autneu.2022.102988.

    PMID: 35613491
  23. 23

    Fludrocortisone Is Associated With a Higher Risk of All-Cause Hospitalizations Compared With Midodrine in Patients With Orthostatic Hypotension.

    Grijalva CG, Biaggioni I, Griffin MR, Shibao CA

    Journal of the American Heart Association 2017; (6(10)) doi:10.1161/JAHA.117.006848.

    PMID: 29025750
  24. 24

    Trick or Treat? Licorice-Induced Hypokalemia: A Case Report.

    Benge E, Shah P, Yamaguchi L, Josef V

    Cureus 2020; (12(11)):e11656 doi:10.7759/cureus.11656.

    PMID: 33391895
  25. 25

    When Treatment Becomes the Trigger: Fludrocortisone-Associated Hypokalaemia in an Older Adult.

    Phyo KC, Kyaw Z, Pyone ZM, et al.

    Cureus 2026; (18(7)):e112116 doi:10.7759/cureus.112116.

    PMID: 42558803
  26. 26

    Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS) : Endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH).

    Fanciulli A, Jordan J, Biaggioni I, et al.

    Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2018; (28(4)):355-362 doi:10.1007/s10286-018-0529-8.

    PMID: 29766366
  27. 27

    How to treat cardiovascular autonomic failure in Parkinson's disease.

    Fanciulli A, Leys F, Höglinger G, Jost WH

    Journal of neural transmission (Vienna, Austria : 1996) 2026; (133(2)):215-228 doi:10.1007/s00702-025-03096-7.

    PMID: 41484430

This page explains treatment and home blood-pressure monitoring for orthostatic hypotension in PAF for informational purposes only and does not constitute medical advice. A clinician should individualize salt, fluid, medication, and blood-pressure recommendations for you.